LivaNova (NASDAQ:LIVN) Hits New 52-Week High – Here’s What Happened

LivaNova PLC (NASDAQ:LIVN) shares reached a new 52-week high on Thursday . The company traded as high as $65.57 and last traded at $64.0550, with a volume of 41233 shares. The stock had previously closed at $64.06.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. Weiss Ratings reissued a “sell (d+)” rating on shares of LivaNova in a research note on Monday. Barclays lifted their price target on shares of LivaNova from $55.00 to $58.00 and gave the company an “equal weight” rating in a research note on Thursday, August 21st. The Goldman Sachs Group set a $55.00 price objective on LivaNova and gave the stock a “neutral” rating in a research report on Wednesday, October 1st. Mizuho increased their target price on shares of LivaNova from $65.00 to $70.00 and gave the stock an “outperform” rating in a report on Thursday, November 13th. Finally, Needham & Company LLC reissued a “buy” rating and set a $64.00 price target on shares of LivaNova in a research report on Wednesday, September 3rd. Five equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $62.43.

LivaNova Price Performance

The business has a fifty day moving average of $55.80 and a two-hundred day moving average of $51.30. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.12 and a current ratio of 1.33. The firm has a market capitalization of $3.47 billion, a price-to-earnings ratio of -15.89 and a beta of 1.02.

Hedge Funds Weigh In On LivaNova

Large investors have recently modified their holdings of the stock. Tudor Investment Corp ET AL acquired a new position in LivaNova in the 3rd quarter valued at about $1,746,000. CIBC Bancorp USA Inc. bought a new stake in shares of LivaNova during the third quarter worth approximately $304,000. Oberweis Asset Management Inc. bought a new stake in shares of LivaNova during the third quarter worth approximately $9,743,000. Shelton Capital Management acquired a new position in shares of LivaNova in the third quarter valued at approximately $325,000. Finally, Quarry LP bought a new position in shares of LivaNova during the third quarter worth approximately $36,000. 97.64% of the stock is owned by institutional investors.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.